Veterinary Medicines

Pulmotil AC 250 mg/mL concentrate for oral solution for use in drinking water or milk replacer for chickens, turkeys, pigs and calves

Authorised
  • Tilmicosin
Download as PDF

Product identification

Medicine name:
Pulmotil AC, 250 mg/ml, concentré pour solution orale à ajouter à de l’eau de boisson pour poulet, porc, dinde, ou à un aliment d’allaitement pour veaux
Pulmotil AC, 250 mg/ml, Konzentrat zur Herstellung einer Lösung zum Eingeben über Trinkwasserfür Hühner, Truthühner, Schweine oder Milchaustauscher für Kälber
Pulmotil AC 250 mg/mL concentrate for oral solution for use in drinking water or milk replacer for chickens, turkeys, pigs and calves
Active substance:
  • Tilmicosin
Target species:
  • Chicken
  • Turkey
  • Pig
  • Cattle (pre-ruminant)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Tilmicosin
    250.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Concentrate for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        12
        day
    • Turkey
      • Meat and offal
        19
        day
    • Pig
      • Meat and offal
        14
        day
    • Cattle (pre-ruminant)
      • Meat and offal
        42
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • Polyethylene naphthalate amber coloured bottle containing 960 mL of veterinary medicinal product, with a polypropylene screw top and polyethylene/aluminium/polyethylene terephthalate seal.
  • Polyethylene naphthalate amber coloured bottle containing 240 mL of veterinary medicinal product, with a polypropylene screw top and polyethylene/aluminium/polyethylene terephthalate seal.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 867/99/08/0642
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0102/001
Concerned member states:
  • Belgium
  • Greece
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain

Documents

Combined File of all Documents

English (PDF)
Published on: 16/02/2022
Download